Levonantradol (original) (raw)

dbo:abstract

• Levonantradol ist ein synthetisches Analogon von Tetrahydrocannabinol und zählt damit zu den Cannabinoiden. (de)
• Levonantradol (CP 50,556-1) is a synthetic cannabinoid analog of dronabinol (Marinol) developed by Pfizer in the 1980s. It is around 30x more potent than THC, and exhibits antiemetic and analgesic effects via activation of CB1 and CB2 cannabinoid receptors. Levonantradol is not currently used in medicine as dronabinol or nabilone are felt to be more useful for most conditions, however it is widely used in research into the potential therapeutic applications of cannabinoids. (en)
• Levonantradol es un químico de síntesis análogo del canabinoide dronabinol (Marinol). Posee efectos antieméticos y analgésicos, probablemente relacionados con la unión a los receptores de canabinoides CB1 y CB2.​ (es)
• Il Levonantradolo (CP 50,556-1) è un cannabinoide sintetico affine al dronabinol (Marinol) sviluppato da Pfizer negli anni ottanta. È circa trenta volte più potente del THC, e ha effetti antiemetici e analgesici grazie all'attivazione dei recettori cannabinoidi CB1 e CB2. Il Levonantradol non è attualmente più usato in medicina in quanto il dronabinol e il nabilone sono considerati più efficaci nella maggior parte degli usi, tuttavia viene ampiamente utilizzato nella ricerca delle potenziali applicazioni terapeutiche dei cannabinoidi. (it)
• Levonantradol är ett som hör till gruppen cannabinoider, och har testats mot illamående. Preparatets kemiska summaformel är C27H35NO4 och dess molmassa 437,571 g/mol. Substansen är narkotikaklassad och ingår i förteckning II i Sverige, men finns för närvarande inte upptagen i förteckningarna i internationella narkotikakonventiomer. (sv)

dbo:casNumber

• 71048-87-8

dbo:fdaUniiCode

• 03S640ADSK

dbo:pubchem

• 5361881

dbo:thumbnail

• wiki-commons:Special:FilePath/Levonantradol.svg?width=300

dbo:wikiPageID

• 4840286 (xsd:integer)

dbo:wikiPageLength

• 9965 (xsd:nonNegativeInteger)

dbo:wikiPageRevisionID

• 1081875379 (xsd:integer)

dbo:wikiPageWikiLink

• dbr:Cannabinoid_receptor
• dbr:Robinson_annulation
• dbr:Blood-brain_barrier
• dbr:Antiemetic
• dbr:Pfizer
• dbc:Acetate_esters
• dbc:Cannabinoids
• dbc:Pfizer_brands
• dbc:Phenol_ethers
• dbr:Chemical_synthesis
• dbc:Phenanthridines
• dbr:Synthon
• dbr:Codeine
• dbr:Nabilone
• dbr:CP_47,497
• dbr:Adenylyl_cyclase
• dbr:Dronabinol
• dbr:Analgesic
• dbr:Cyclic_adenosine_monophosphate
• dbr:Ethyl_acetoacetate
• dbr:Ethyl_chloroformate
• dbr:Ethyl_formate
• dbc:CB1_receptor_agonists
• dbr:Michael_addition
• dbr:THC
• dbr:Methyl_vinyl_ketone
• dbr:Cannabinoid
• dbr:Nociceptive
• dbr:Analog_(chemistry)
• dbr:G-protein_coupled_receptors
• dbr:Polyphosphoric_acid
• dbr:Dane_salt
• dbr:File:Nantradol_synthesis.svg

dbp:atcPrefix

• none (en)

dbp:c

• 27 (xsd:integer)

dbp:casNumber

• 71048 (xsd:integer)

dbp:chemspiderid

• 4514867 (xsd:integer)

dbp:h

• 35 (xsd:integer)

dbp:iupacName

• [- 9-hydroxy- 6-methyl- 3-[-5-phenylpentan- 2-yl]oxy- 5,6,6a,7,8,9,10,10a-octahydrophenanthridin- 1-yl] acetate (en)

dbp:n

• 1 (xsd:integer)

dbp:o

• 4 (xsd:integer)

dbp:pubchem

• 5361881 (xsd:integer)

dbp:smiles

• O=CC (en)

dbp:stdinchi

• 1 (xsd:integer)

dbp:stdinchikey

• FFVXQGMUHIJQAO-BFKQJKLPSA-N (en)

dbp:unii

• 3 (xsd:integer)

dbp:verifiedrevid

• 447558276 (xsd:integer)

dbp:width

• 200 (xsd:integer)

dbp:wikiPageUsesTemplate

• dbt:Cannabinoidergics
• dbt:Cannabinoids
• dbt:Cite_journal
• dbt:Drugbox
• dbt:Hallucinogens
• dbt:Refbegin
• dbt:Refend
• dbt:Reflist
• dbt:Short_description
• dbt:Cascite
• dbt:Chemspidercite
• dbt:Drugbankcite
• dbt:Fdacite
• dbt:Stdinchicite

dcterms:subject

• dbc:Acetate_esters
• dbc:Cannabinoids
• dbc:Pfizer_brands
• dbc:Phenol_ethers
• dbc:Phenanthridines
• dbc:CB1_receptor_agonists

rdf:type

• owl:Thing
• dul:ChemicalObject
• dbo:ChemicalSubstance
• wikidata:Q8386
• yago:Abstraction100002137
• yago:Chemical114806838
• yago:Compound114818238
• yago:Element114840755
• yago:Ester114850483
• yago:Material114580897
• yago:Matter100020827
• yago:OrganicCompound114727670
• yago:Part113809207
• yago:PhysicalEntity100001930
• yago:Quintessence114847103
• yago:Relation100031921
• dbo:Drug
• yago:Substance100019613
• yago:WikicatAcetateEsters
• yago:WikicatPhenolEthers
• umbel-rc:DrugProduct

rdfs:comment

• Levonantradol ist ein synthetisches Analogon von Tetrahydrocannabinol und zählt damit zu den Cannabinoiden. (de)
• Levonantradol (CP 50,556-1) is a synthetic cannabinoid analog of dronabinol (Marinol) developed by Pfizer in the 1980s. It is around 30x more potent than THC, and exhibits antiemetic and analgesic effects via activation of CB1 and CB2 cannabinoid receptors. Levonantradol is not currently used in medicine as dronabinol or nabilone are felt to be more useful for most conditions, however it is widely used in research into the potential therapeutic applications of cannabinoids. (en)
• Levonantradol es un químico de síntesis análogo del canabinoide dronabinol (Marinol). Posee efectos antieméticos y analgésicos, probablemente relacionados con la unión a los receptores de canabinoides CB1 y CB2.​ (es)
• Il Levonantradolo (CP 50,556-1) è un cannabinoide sintetico affine al dronabinol (Marinol) sviluppato da Pfizer negli anni ottanta. È circa trenta volte più potente del THC, e ha effetti antiemetici e analgesici grazie all'attivazione dei recettori cannabinoidi CB1 e CB2. Il Levonantradol non è attualmente più usato in medicina in quanto il dronabinol e il nabilone sono considerati più efficaci nella maggior parte degli usi, tuttavia viene ampiamente utilizzato nella ricerca delle potenziali applicazioni terapeutiche dei cannabinoidi. (it)
• Levonantradol är ett som hör till gruppen cannabinoider, och har testats mot illamående. Preparatets kemiska summaformel är C27H35NO4 och dess molmassa 437,571 g/mol. Substansen är narkotikaklassad och ingår i förteckning II i Sverige, men finns för närvarande inte upptagen i förteckningarna i internationella narkotikakonventiomer. (sv)

rdfs:label

• Levonantradol (de)
• Levonantradol (es)
• Levonantradolo (it)
• Levonantradol (en)
• Levonantradol (sv)

owl:sameAs

• freebase:Levonantradol
• yago-res:Levonantradol
• wikidata:Levonantradol
• dbpedia-de:Levonantradol
• dbpedia-es:Levonantradol
• dbpedia-it:Levonantradol
• dbpedia-sh:Levonantradol
• dbpedia-sr:Levonantradol
• dbpedia-sv:Levonantradol
• https://global.dbpedia.org/id/ykpg

prov:wasDerivedFrom

• wikipedia-en:Levonantradol?oldid=1081875379&ns=0

foaf:depiction

• wiki-commons:Special:FilePath/Levonantradol.svg
• wiki-commons:Special:FilePath/Nantradol_synthesis.svg

foaf:isPrimaryTopicOf

• wikipedia-en:Levonantradol

is dbo:wikiPageRedirects of

• dbr:CP_50,556-1
• dbr:Nantradol

is dbo:wikiPageWikiLink of

• dbr:C27H35NO4
• dbr:List_of_psychedelic_drugs
• dbr:Misuse_of_Drugs_Act_1977
• dbr:Cannabinoid
• dbr:Cannabinoid_receptor_type_1
• dbr:List_of_drugs:_Le
• dbr:CP_50,556-1
• dbr:Nantradol

is foaf:primaryTopic of

• wikipedia-en:Levonantradol